Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(CDP6038----1件: 46 💬
22-CdA1件: Cladribine (2-CdA)1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
32-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
42-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
52-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
62-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
72-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
82-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
92-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
102-chloro-2'-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
112-chloro-2'-deoxyadenosine (2-CdA)1件: Cladribine (2-CdA)1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
122-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
132-chloro-2’-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine (2-CdA)		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
142-chloro-2’-deoxyadenosine (2-CdA)1件: Cladribine (2-CdA)1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
15Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cDNA1件: Agalsidase alfa1件: Agalsidase alfa 💬1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19 💬
16ALLO-ASC-CD----1件: 96 💬
17Anti CD3 monoclonal antibody----1件: 97 💬
18Anti-CD19-CAR-T cells----1件: 49 💬
19Anti-CD20 antibody----1件: 64 💬
20Anti-CD20 B cell depletion with Truxima----1件: 49 💬
21Anti-CD20 small modular immunopharmaceutical, WYE-400087----1件: 46 💬
22Anti-CD25 Humanized Monoclonal Antibody----1件: 13 💬
23Anti-CD28dAb----3件: 49, 53, 160 💬
24Anti-CD31件: Muromonab (Muromonab-CD3)---2件: 96, 97 💬
25Anti-CD3 Monoclonal antibody1件: Muromonab (Muromonab-CD3)---2件: 96, 97 💬
26Anti-CD40L1件: Toralizumab (Anti-CD40L)1件: Toralizumab 💬1件: CD40LG 💬14件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬1件: 63 💬
27Anti-CD40LdAb----1件: 63 💬
28Anti-CD45----3件: 60, 65, 285 💬
29Anti-CD52 monoclonal antibody----1件: 13 💬
30AP-CD/LD----1件: 6 💬
31Assigned Interventions CD19/BCMA CAR T-cells----3件: 49, 51, 53 💬
32Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene----1件: 65 💬
33AUTOLOGOUS CD34+ CELLS TRANSDUCED EX-VIVO WITH THE PCCLCHIMGP91/VSVG LENTIVIRAL VECTOR----1件: 65 💬
34AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING THE HUMAN SGSH GENE----1件: 19 💬
35Autologous CD34+ cells transduced with a lentiviral vector encoding the ARSA cDNA----1件: 19 💬
36AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH LENTI-D VECTOR ENCODING ABCD1 CDNA----1件: 20 💬
37Autologous CD34+ cells transduced with the Lentiviral vector containing the human Wiskott Aldrich Sy----1件: 65 💬
38Autologous CD34+ cells transduced with WASP lentiviral vector----1件: 65 💬
39Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes for the human Wiskott Aldrich Syndrome (WAS) cDNA sequence----1件: 65 💬
40Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII----1件: 19 💬
41Autologous CD34+ HSCs transduced ex vivo with EFS lentiviral vector encoding for the human ADA gene----1件: 65 💬
42AUTOLOGOUS CD34+CELLS TRANSDUCED WITH THE W1.6_HWASP_WPRE (VSVG) LENTIVIRAL VECTOR----1件: 65 💬
43Autologous CD34-selected peripheral blood stem cells transplant----1件: 96 💬
44Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13 💬
45Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA----1件: 20 💬
46Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells----1件: 51 💬
47BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬		--1件: 86 💬
48Biologic: IC14 (monoclonal antibody against human CD14)----1件: 2 💬
49Blinded CDCA 250 mg TID1件: Chenodeoxycholic acid (CDCA)1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
50BT061 (CD4 monoclonal antibody)----1件: 46 💬
51CARBIDOPA (CD)1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
52CD----8件: 6, 13, 46, 51, 63, 96, 97, 265 💬
53CD-4 guided therapy interruption----1件: 265 💬
54CD-C-Food----1件: 96 💬
55CD-LD CR----1件: 6 💬
56CD-LD IR----1件: 6 💬
57CD19-directed humanised afucosylated monoclonal antibody----1件: 11 💬
58CD19/BCMA CAR T-cells----2件: 16, 61 💬
59CD3/CD19 depleted leukocytes----1件: 284 💬
60CD3/CD19 neg allogeneic BMT----1件: 65 💬
61CD3/CD19 negative allogeneic hematopoietic stem cells----1件: 65 💬
62CD3/CD19 negative hematopoietic stem cells----1件: 85 💬
63CD34 selected autologous hematopoietic cells----1件: 51 💬
64CD34 Stem Cell Selection Therapy----3件: 60, 65, 284 💬
65CD34+----1件: 65 💬
66CD34+ CELLS----1件: 285 💬
67CD34+ cells transduced with ADA retrovir----1件: 65 💬
68CD34+ enriched, T Cell Depleted donor stem cell product----1件: 326 💬
69CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT----1件: 65 💬
70CD34+ selected cells----1件: 285 💬
71CD34+CELLS----2件: 65, 285 💬
72CD34+SC----1件: 51 💬
73CD45RA depleted leukocytes----1件: 284 💬
74CD62L- Tem----1件: 60 💬
75CD7 CAR T-cells----3件: 50, 96, 97 💬
76CDCA1件: Chenodeoxycholic acid (CDCA)1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
77CDCA Weight-Based Dose TID1件: Chenodeoxycholic acid (CDCA)1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
78CDED+PEN+dairy products----1件: 96 💬
79CDMARD----1件: 46 💬
80CDNF----1件: 6 💬
81CDP3194----1件: 49 💬
82CDP3231件: CDP323---1件: 13 💬
83CDP6038----2件: 46, 96 💬
84CDP6038 (olokizumab)1件: Olokizumab1件: Olokizumab 💬1件: IL6 💬51件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬1件: 46 💬
85CDP7657----1件: 49 💬
86CDP870----3件: 46, 96, 271 💬
87CDP870 100mg----1件: 46 💬
88CDP870 200mg----1件: 46 💬
89CDP870 400mg----1件: 46 💬
90CDP870 Fab'-PEG----1件: 46 💬
91CDX----2件: 222, 240 💬
92CDX 6114----1件: 240 💬
93CDX-1135----1件: 222 💬
94CDZ173----2件: 53, 65 💬
95Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi----1件: 19 💬
96Certolizumab pegol (CDP870)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
97Certolizumab pegol (CDP870, CZP)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96 💬
98Certolizumab pegol (CDP870, tradename Cimzia)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
99Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg)1件: Certolizumab pegol1件: Certolizumab pegol 💬1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
100Chimeric human/mouse anti-CD-20 monoclonal antibody----1件: 46 💬
101CHX A-DTPA anti-CD66 antibody1件: Pentetic acid1件: Pentetic acid 💬--1件: 28 💬
102CHX-A-DTPA-Anti-CD661件: Pentetic acid1件: Pentetic acid 💬--1件: 28 💬
103Combination of a single dose anti-CD20 antibody and bortezomib1件: Bortezomib1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 61 💬
104Crohn's disease exclusion diet (CDED)----1件: 96 💬
105CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE----1件: 19 💬
106Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65 💬
107Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells----1件: 65 💬
108Cytolytic CD4+ T cells----1件: 13 💬
109Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant----1件: 62 💬
110Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
111Depletion in CD45RA graft donor----1件: 65 💬
112Depletion of CD3/CD19 in an autologous stem cell transplant----2件: 49, 51 💬
113Duodopa LD/CD 20/5 mg/mL2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
114EF1aS-ADA lentiviral vector gene modified autologous CD34+ cells----1件: 65 💬
115EF1aS-ADA lentiviral vector transduced patient CD34+ cells----1件: 65 💬
116Engineered humanized monoclonal anti-human CD19 antibody.----1件: 46 💬
117Engineered humanized monoclonal anti-human CD19 antibody. Lot Numbers: 1-FIN-1588 (9.6mg/ml)----1件: 46 💬
118ER CD-LD----1件: 6 💬
119Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4i-EF1alpha-hgammac-OPT vector----1件: 65 💬
120Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length LAMB3 cDNA.----1件: 36 💬
121Fc- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
122Frozen autologous CD34+ hematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the a-L-iduronidase cDNA, in their final formulation medium.----1件: 19 💬
123G1XCGD transduced CD34+ cells----1件: 65 💬
124Gene-Transduced Autologous CD34+ Stem Cells----1件: 65 💬
125GSK2018682 CD2 Capsule----1件: 13 💬
126GSK2018682 CD3 micronised Tablet----1件: 13 💬
127GSK2018682 CD3 non-micronised Tablet----1件: 13 💬
128GSK2018682 CD3 non-micronised Tablet in fed state----1件: 13 💬
129Human glucocerebrosidase cDNA----1件: 19 💬
130Human IgG4 monoclonal antibody against CD40----1件: 46 💬
131Human monoclonal antibody directed against CD20 on B-cells----1件: 46 💬
132Humanised anti-CD 20 antibody----1件: 46 💬
133Humanised anti-CD4 IgG1 monoclonal----1件: 46 💬
134Humanized recombinant IgG4 monoclonal antibody against CD-127----1件: 97 💬
135HuMax-CD201件: Ofatumumab (HuMax-CD20)1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 13, 46 💬
136HUMAX-CD38----2件: 28, 63 💬
137HuMax-CD38, 3003-005----1件: 28 💬
138HuMax-CD41件: Zanolimumab (Humax-cd4)1件: Zanolimumab 💬1件: CD4 💬14件: Antigen processing and presentation, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Yersinia infection 💬1件: 46 💬
139Indium 111-radiolabelled anti-CD661件: Indium---1件: 28 💬
140Indium­ 111 ­labelled Anti­-CD661件: Indium---1件: 28 💬
141INEBILIZUMAB
(Inebilizumab-cdon)		1件: Inebilizumab (inebilizumab-cdon)1件: Inebilizumab (Inebilizumab-cdon) 💬1件: CD19 💬5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬4件: 11, 13, 51, 300 💬
142Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)----1件: 65 💬
143Infusion of autologous EFS-ADA LV CD34+ cells----1件: 65 💬
144Intravitreal autologous CD34+ cells----1件: 90 💬
145IPX203 ER CD-LD----1件: 6 💬
146IR CD-LD----1件: 6 💬
147IR CD-LD (carbidopa-levodopa) tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
148IR LD / CD----1件: 6 💬
149IR LD/CD----1件: 6 💬
150LD/CD----1件: 6 💬
151Lentiviral vector transduced CD34+ cells----1件: 65 💬
152Levodopa/Carbidopa (LD/CD)2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
153Minibody against CD8 conjugated to desferrioxamine labeled with zirconium Zr 891件: Deferoxamine1件: Deferoxamine 💬--2件: 51, 53 💬
154Muromonab-CD31件: Muromonab (Muromonab-CD3)---1件: 60 💬
155NI-0401 (anti-CD3 mAB)1件: Muromonab (Muromonab-CD3)---1件: 96 💬
156ONO-2160/CD----1件: 6 💬
157Open-Label CDCA 250 mg TID1件: Chenodeoxycholic acid (CDCA)1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
158PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----1件: 65 💬
159Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells----1件: 65 💬
160Phase1 : CDED/Modulen™IBD® + Maintenance therapy----1件: 96 💬
161Plerixafor mobilization of autologous CD117 stem cells1件: Plerixafor1件: Plerixafor 💬1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 299 💬
162RAG1 LV CD34+ cells----1件: 65 💬
163Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A----1件: 19 💬
164Recombinant humanized anti-CD20 monoclonal antibody----1件: 13 💬
165Rescue Medication CDCA 250 mg TID1件: Chenodeoxycholic acid (CDCA)1件: Chenodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 263 💬
166Retroviral SF71-gp91phox transduced CD34+ cells----1件: 65 💬
167Rituximab (anti-CD20)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 53 💬
168Routine Treatment of CD----1件: 96 💬
169Semi continuous intra-oral administration of LD/CD----1件: 6 💬
170Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre----1件: 65 💬
171Standard LD/CD----1件: 6 💬
172Suspension of autologous CD34+cells transduced with the G1XCGD viral vector----1件: 65 💬
173T-Cell Depleted & CD34+Select/w/StemCell Enriched Product----1件: 65 💬
174TL011, anti CD20, for the treatment of rheumatoid arthritis----1件: 46 💬
175TPO-RAs combining anti-CD 20 monoclonal antibody----1件: 63 💬
176Transduced CD34+ Cells----1件: 285 💬
177Transduced CD34+ hematopoietic stem cell----2件: 19, 20 💬
178Transduced patient CD34+ cells----1件: 65 💬
179Yttrium-90 radiolabelled anti-CD66 antibody1件: Yttrium Y-90---1件: 28 💬
180Yttrium­90 radiolabelled anti­CD66----1件: 28 💬